Fig. 6From: Serotonin induced hepatic steatosis is associated with modulation of autophagy and notch signaling pathwayInactivation of autophagy or Notch signaling reduces serotonin mediated cell survival while increasing serotonin induced drug resistance in HepG2 and SK-Hep1 cells. a HepG2 and SK-Hep1 cells were grown in 96 well plates treated with serotonin (0.5 mM), 3-MA (4 mM), serotonin plus 3-MA, avagacestat (2 μM), serotonin plus avagacestat, FLI-06 (1 μM), and serotonin plus FLI-06 as indicated for 48 h. b Similarly, HepG2 and SK-Hep1 cells were grown in 96-well plates and treated with serotonin (0.5 mM), sorafenib (2.5 μM), serotonin plus sorafenib, regorafenib (0.5 μM), and regorafenib plus serotonin as indicated for 48 h. Cells were treated with 5 μl MTT reagent/well (5 mg/ml in PBS) and cell survival was measured by reading the plate at 570 nm using a Fluostar Omega plate reader. Each combination of the cell line and drug concentration was set up in triplicate. Data are expressed as the mean ± S.D. * p < 0.1, **p < 0.01 compared to control. ββP < 0.01 compared to 3-MA. ### p < 0.001 compared to sorafenib treatment. †††p < 0.001 compared to regorafenib treatment. Serot.-Serotonin. AVG- Avagacestat. 3-MA- 3-Methyladenine. OA- Oleic acidBack to article page